Joyce M. S. Chan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Joyce M. S. Chan has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Claudia Monaco
University of Oxford
1 shared publication Jennifer E. Cole
Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom
1 shared publicationJordi L. Tremoleda
Medical Research Council-Clinical Sciences Centre, Imperial College London, and Centre for Trauma Sciences, Queen Mary University of London, London, United Kingdom
1 shared publicationKishore K. Bhakoo
The Laboratory of Molecular Imaging, Singapore Bioimaging Consortium, Agency for Science, Technology and Research (ASTAR), Singapore
1 shared publication- Kishore K. Bhakoo
Singapore Bioimaging Consortium (SBIC), Agency for Science, Technology and Research (A*STAR), Helios, Singapore 138667, Singapore
1 shared publication - Maggie S. H. Cheung
Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, People's Republic of China
1 shared publication
Latest Publications
- 1 May 2018
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 67 (5) , 1571-1583.e3
Imaging vulnerable plaques by targeting inflammation in atherosclerosis using fluorescent-labeled dual-ligand microparticles of iron oxide and magnetic resonance imaging
- 1 May 2018
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 67 (5) , 1571-1583.e3
Imaging vulnerable plaques by targeting inflammation in atherosclerosis using fluorescent-labeled dual-ligand microparticles of iron oxide and magnetic resonance imaging
- Open Access
- 2 January 2017
- Published by Wiley in Clinical and Translational Medicine
- Vol. 6 (1) , 1
MRI detection of endothelial cell inflammation using targeted superparamagnetic particles of iron oxide (SPIO)
Background: There is currently no clinical imaging technique available to assess the degree of inflammation associated with atherosclerotic plaques. This study aims to develop targeted superparamagnetic particles of iron oxide (SPIO) as a magnetic resonance imaging (MRI) probe for detecting inflamed endothelial cells.Methods: The in vitro study consists of the characterisation and detection of inflammatory markers on activated endothelial cells by immunocytochemistry and MRI using biotinylated anti‐P‐selectin and anti‐VCAM‐1 (vascular cell adhesion molecule 1) antibody and streptavidin conjugated SPIO.Results: Established an in vitro cellular model of endothelial inflammation induced with TNF‐α (tumor necrosis factor alpha). Inflammation of endothelial cells was confirmed with both immunocytochemistry and MRI. These results revealed both a temporal and dose dependent expression of the inflammatory markers, P‐selectin and VCAM‐1, on exposure to TNF‐α.Conclusion: This study has demonstrated the development of an in vitro model to characterise and detect inflamed endothelial cells by immunocytochemistry and MRI. This will allow the future development of contrast agents and protocols for imaging vascular inflammation in atherosclerosis. This work may form the basis for a translational study to provide clinicians with a novel tool for the in vivo assessment of atherosclerosis.
- 2 January 2017
- Published by Wiley in Clinical and Translational Medicine
- Vol. 6 (1) , 1
Open AccessMRI detection of endothelial cell inflammation using targeted superparamagnetic particles of iron oxide (SPIO)
Background: There is currently no clinical imaging technique available to assess the degree of inflammation associated with atherosclerotic plaques. This study aims to develop targeted superparamagnetic particles of iron oxide (SPIO) as a magnetic resonance imaging (MRI) probe for detecting inflamed endothelial cells.Methods: The in vitro study consists of the characterisation and detection of inflammatory markers on activated endothelial cells by immunocytochemistry and MRI using biotinylated anti‐P‐selectin and anti‐VCAM‐1 (vascular cell adhesion molecule 1) antibody and streptavidin conjugated SPIO.Results: Established an in vitro cellular model of endothelial inflammation induced with TNF‐α (tumor necrosis factor alpha). Inflammation of endothelial cells was confirmed with both immunocytochemistry and MRI. These results revealed both a temporal and dose dependent expression of the inflammatory markers, P‐selectin and VCAM‐1, on exposure to TNF‐α.Conclusion: This study has demonstrated the development of an in vitro model to characterise and detect inflamed endothelial cells by immunocytochemistry and MRI. This will allow the future development of contrast agents and protocols for imaging vascular inflammation in atherosclerosis. This work may form the basis for a translational study to provide clinicians with a novel tool for the in vivo assessment of atherosclerosis.